Jeffrey R. Strawn, MD

  • 7Articles
  • 58.6KReads
  • 2006–2022Active
  • 26Collaborators
  • 243Citations

About

Jeffrey R. Strawn, MD, is affiliated with the College of Medicine at the University of Cincinnati and the Department of Pediatrics at Cincinnati Children’s Hospital Medical Center. His publications, spanning from 2006 to 2022, focus on child and adolescent psychiatry, particularly anxiety disorders, bipolar disorder, depression, and related metabolic and neuroleptic complications. His research topics include pharmacotherapy following cognitive behavioral therapy in anxious youth, the use of escitalopram in adolescents with generalized anxiety disorder, thyroid function screening in pediatric mood and anxiety disorders, and treatment considerations for co-occurring bipolar and anxiety disorders.

Publications

JCP
Pharmacotherapy After CBT in Anxious Youth
Original Research

Pharmacotherapy After CBT in Anxious Youth

December 5, 2022

This study of youth with anxiety disorders compared cognitive-behavioral therapy (CBT) non-remitters who initiated pharmacotherapy to those who did not and sought to identify predictors of the decision to...
, , , et al
JCP
Original Research

Escitalopram in Adolescents With GAD

August 25, 2020

This study evaluated the efficacy and tolerability of escitalopram in adolescents with generalized anxiety disorder as well as the impact of variants in genes and CYP2C19 phenotypes on response...
, , , et al
JCP
Original Research

Thyroid Function in Youth With Mood and Anxiety Disorders

August 6, 2019

Abnormal thyroid hormone levels are among the most common nonpsychiatric causes of mood and anxiety symptoms. This retrospective study examines the extent of the issue in youth with mood...
, , , et al
JCP
Article

Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis

January 29, 2019

When you treat youth with anxiety disorders, are your decisions evidence-based? This meta-analysis examined efficacy and tolerability of agents studied for pediatric anxiety in double-blind, placebo-controlled trials. Read the...
, ,
JCP
Article

Psychopharmacologic Treatment of Posttraumatic Stress Disorder in Children and Adolescents: A Review

April 20, 2010

, , , et al
JCP
Letter to the Editor

Early Bicarbonate Loading and Dantroline for Ziprasidone/Haloperidol-Induced Neuroleptic Malignant Syndrome

April 15, 2006

,
JCP
Article

Pharmacologic Treatment Considerations in Co-Occurring Bipolar and Anxiety Disorders.

January 16, 2006

, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe